David W. Robinson
David Robinson has over 40 years of commercialization experience in the biopharma industry in multiple therapeutic areas. Mr. Robinson is a proven commercial leader with a history of launching category-defining therapies. He has extensive end-to-end launch expertise spanning strategic launch planning and execution, global market access, reimbursement, building and motivating commercial teams, and spearheading effective […]
Chad Clatterbaugh
A seasoned leader in the field of ophthalmology, Mr. Clatterbaugh brings over two decades of transformative leadership and strategic vision to his role as Chief of Staff, Ocular Therapeutix. With a proven track record of driving innovation, maximizing operational efficiency, and fostering collaborative environments, Mr. Clatterbaugh is dedicated to shaping the future of ocular healthcare. […]
Art Ciociola
Art Ciociola is a Global Regulatory Affairs and Quality Assurance executive, specializing in ocular drug and device development with over 35 years of pharmaceutical drug development experience, who has played an instrumental role in the global approval of 18 new chemical entity drugs across multiple therapeutic areas, including ophthalmology, oncology, neurosciences, metabolic diseases, infectious diseases, […]
Antony Mattessich
Antony Mattessich joined Ocular as Chief Executive Officer in August of 2017. Prior to joining the company, he was Managing Director of Mundipharma International based in Cambridge, England. Previous to his time at Mundipharma, Antony ran the US respiratory, dermatology and pediatrics group at Novartis. He also held several positions at Bristol-Myers Squibb, among them, […]
Christopher White
Christopher White brings over 25 years of operations management, business development, partnering and strategic planning experience in the biopharmaceutical industry. Prior to joining Ocular, Mr. White was the Chief Operating Officer at Silver Creek Pharmaceuticals, a private Bay Area biotechnology company focused on the development of novel regenerative medicines. Prior to his work at Silver […]
Philip Strassburger, Esq
Phil brings to Ocular Therapeutix more than 30 years of experience as a pharmaceutical lawyer specializing in protection of intellectual property rights and regulatory strategies. His background and education as a Chemical Engineer, in the Netherlands and U.S., provide a valuable, deep knowledge of science and technology. He began his legal career at law firms […]
Tracy Smith
Tracy brings to Ocular Therapeutix more than 20 years of success delivering people strategy for domestic and international biopharmaceutical operations and designing human capital agendas to transform business cultures. Prior to joining the Company, Tracy was the Global Head of HR for HiFiBiO Therapeutics, a multi-national company leading several change and structural initiatives during their […]
Rabia Gurses Ozden, M.D.
Rabia Gurses Ozden, MD brings over 15 years of experience in clinical development, clinical operations, and pharmacovigilance in pharmaceutical and medical device development with proven capabilities in global program and project management as well as experience interacting with the FDA, EMA, PMDA, and CFDA for regulatory filings, new clinical endpoint development, and label negotiations. Prior […]
Karen-Leigh Edwards, PhD, MBA
Karen-Leigh Edwards joined Ocular Therapeutix in September 2021. Her career expertise includes senior global leadership roles in Product Development, Manufacturing & Operations and Business Development. Karen-Leigh is well positioned to translate corporate vision into executable strategies to deliver marketable products and transform lives. Prior to Ocular, Karen-Leigh held a variety of positions at Alexion, Biogen […]
Scott Corning
Scott Corning has over 20 years of commercial ophthalmic pharmaceutical and medical device experience, covering a range of pharmaceuticals, ophthalmic surgical equipment and diagnostic devices. Prior to joining Ocular Therapeutix in 2010, Mr. Corning held marketing management positions at Alcon in both the pharmaceutical and surgical divisions, and prior to that at Summit Technology, and […]